Transformation Strategy Director
Levi's
About this role
A Director, Transformation Strategy at Levi Strauss & Co. drives enterprise-wide transformation projects that align with financial, operational, and strategic goals. The role focuses on optimizing structural economics, enhancing financial viability, and improving decision-making through data-driven insights.
Skills
Qualifications
About Levi's
levi.comThe official Levi's® US website has the best selection of Levi's® jeans, jackets, and clothing for men, women, and kids. Shop the entire collection today.
Recent company news
Yahoo FinanceLululemon just added Chip Bergh, a former Levi's CEO and Swiffer mop creator, to its board
24 hours ago
Simply Wall StreetLevi’s SCAYLE-Powered E-Commerce Overhaul Might Change The Case For Investing In Levi Strauss (LEVI)
23 hours ago
ModaesLululemon Taps Former Levi’s CEO Chip Bergh for Board Role Ahead of CEO Announcement
22 hours ago
Retail TouchPointsLululemon Leaders Hold Firm in Proxy Battle with Founder Chip Wilson, Appoint Former Levi’s CEO Chip Bergh to Board
23 hours ago
TradingViewPeloton, Opendoor, Levi's, Steven Madden, and Norwegian Cruise Line Stocks Trade Up, What You Need To Know
2 days ago
About Levi's
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Levi's.
Salary
$168k – $224k
per year
More jobs at Levi's
Similar Jobs
Senior Manager, Supply Chain Strategy & Business Transformation - Connection Systems
Aptiv
Director: Finance & Strategy Transformation Office
Hewlett Packard Enterprise
Director, Decision Science Portfolio (2 openings)
Novartis
Head of Transformation Office
Bupa
Director, Business Transformation
AstraZeneca
Director, Decision Science, (Renal Portfolio)
Novartis